Amazon.com, Inc. (AMZN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN)

AMZN 226.19

-1.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Rose who wrote (97247)	3/23/2000 12:18:00 PM
From: H James Morris	Read Replies (3) of 164684

Robert, bought Imnr @ 14 1/2. I think some of these low cap bio-techs will see a come back. The Immune Response (IMNR: news, msgs) shares jumped 50 percent after the company announced that recent data suggested that its immune-based Remune therapy may induce HIV immunity. Significantly, it was also effective when used alone. On Feb. 23, the company said Remune had a "significant effect" on 297 Thai patients in a 40-week trial. Analysts were negative then, since the results didn't measure the factors used for U.S. approval. Shares rose 5 1/2 to 16 1/2.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next